LENISHA CAMPBELL: Open Payments
NPI 1780223917 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 29 payments from 10 companies in 2025. Trend: 2023 $156 · 2024 $40 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $204 |
| Vanda Pharmaceuticals Inc. | 3 | $99 |
| Janssen Pharmaceuticals, Inc | 4 | $97 |
| Alkermes, Inc. | 3 | $79 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Neurocrine BioSciences, Inc. | 2 | $63 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Tris Pharma Inc | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: VRAYLAR, FANAPT, REXULTI, INGREZZA, LYBALVI, INVEGA SUSTENNA, SPRAVATO, Auvelity.
Industry payments across FL — which companies pay providers there.
